Concepedia

Publication | Closed Access

Effect of Sucroferric Oxyhydroxide on Fibroblast Growth Factor 23 Levels in Hemodialysis Patients

DOI

12

Citations

21

References

2018

Year

Tomoyasu Otsuki, Kei Utsunomiya, Masari Moriuchi, S. Horikoshi, M. Okamura, Hiroko Suzuki, Makiyo Okamura, Noriaki Maruyama, Nami Shibahara, Masanori Abe
˜The œNephron journals/Nephron journals

Abstract

Treatment of hyperphosphatemia with sucroferric oxyhydroxide was effective in patients on hemodialysis, resulting in decreased serum FGF-23 levels and a reduction in the required dose of saccharated ferric oxide.

References

YearCitations

Page 1